Cargando…
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
Monoclonal antibody (mAb) therapy has opened a new era in the pharmaceutical field, finding application in various areas of research, from cancer to infectious diseases. The IgG isoform is the most used therapeutic, given its long half-life, high serum abundance, and most importantly, the presence o...
Autores principales: | Vacca, Fabiola, Sala, Claudia, Rappuoli, Rino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496014/ https://www.ncbi.nlm.nih.gov/pubmed/36140226 http://dx.doi.org/10.3390/biomedicines10092126 |
Ejemplares similares
-
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022) -
High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
por: Stazzoni, Samuele, et al.
Publicado: (2023) -
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
por: Zurawski, Daniel V., et al.
Publicado: (2020) -
Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies
por: Valeich, Jamie, et al.
Publicado: (2020) -
A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
por: Troisi, Marco, et al.
Publicado: (2022)